Trial
NCT04588948
A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
Regeneron Pharmaceuticals
Condition
Diabetic Macular Edema
Intervention
Intravitreal Aflibercept
Why stopped
Study did not proceed due to funding issues.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-28